GlassScriptPhysician profile
Matthew Kilgo
NPI 1487613436
$13,855.14
in general payments reported to CMS, 2019-2025
15 companies · $2,508 in 2025
The $2,508 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,942 · 2020: $496 · 2021: $1,915 · 2022: $3,475 · 2023: $2,091 · 2024: $1,429 · 2025: $2,508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,593 · Grant: $1,381 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,592.77 |
| Grant | $1,380.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $3,673.45 | 2019-2022 | |
| Allergan, INC. | $2,182.46 | 2019-2022 | |
| Abbvie INC. | $1,968.07 | 2023-2025 | |
| Davol INC. | $1,459.03 | 2022-2025 | Phasix Mesh |
| Axogen | $1,143.74 | 2021-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Motiva USA, LLC | $930.82 | 2024-2025 | |
| Stryker Corporation | $705.49 | 2022 | |
| Tela Bio, INC. | $585.31 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mentor Worldwide LLC | $415.14 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Innovation Technologies INC | $211.31 | 2023 | Irrisept |
| Integra Lifesciences Corporation | $188.57 | 2023-2024 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Tepha INC | $166.44 | 2019 | |
| Baxter Healthcare | $110.37 | 2021 | |
| Galderma Laboratories, L.P. | $71.47 | 2020-2021 | |
| Smith+Nephew, INC. | $43.47 | 2025 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Kilgo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.